Corpus ID: 3611832

Impact of low dose naltrexone (LDN) on antiretroviral therapy (ART) treated HIV+ adults in Mali: A single blind randomized clinical trial

@article{Traore2011ImpactOL,
  title={Impact of low dose naltrexone (LDN) on antiretroviral therapy (ART) treated HIV+ adults in Mali: A single blind randomized clinical trial},
  author={A. Traore and O. Thiero and S. Dao and Fadia F. C. Kounde and O. Faye and M. Ciss{\'e} and Jaquelyn B. McCandless and J. M. Zimmerman and K. Coulibaly and A. Diarra and Mamadou S. Keita and S. Diallo and I. Traore and O. Koita},
  journal={Journal of AIDS and HIV Research},
  year={2011},
  volume={3},
  pages={189-198}
}
  • A. Traore, O. Thiero, +11 authors O. Koita
  • Published 2011
  • Medicine
  • Journal of AIDS and HIV Research
  • To implement an immuno-regulatory approach for reducing or preventing the onset of AIDS symptoms in HIV+ individuals we conducted a single blind nine-month randomized clinical trial to evaluate the impact of low-dose naltrexone (LDN) on asymptomatic HIV+ Mali adults undergoing antiretro virial (ART) treatment with CD4 counts below 350 cell/mm3. We measured differences between groups in CD4 count, CD4%, hemoglobin, viral load, interferon alpha, and standard chemistry panel five times during the… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 21 REFERENCES
    CD4+ T-Lymphocytes Natural Decrease in HAART-Naïve HIV-Infected Adults in Abidjan
    • 10
    Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures.
    • 28
    Darunavir: pharmacokinetics and drug interactions.
    • 292
    Low-Dose Naltrexone Therapy Improves Active Crohn's Disease
    • 113
    • PDF
    The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    • 1,012
    Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy
    • 97
    • PDF
    The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    • 202
    • PDF
    Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
    • 81
    μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication
    • 111
    • PDF